MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference34 articles.
1. Phase II trial of sorafenib in advanced thyroid cancer;Gupta-Abramson;J. Clin. Oncol.,2008
2. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers;Griffith;J. Clin. Oncol.,2006
3. Molecular pathogenesis and mechanisms of thyroid cancer;Xing;Nat. Rev. Cancer,2013
4. A truth serum for cancer—microRNAs have major potential as cancer biomarkers;Chin;Cell Res.,2008
5. Oncomirs—microRNAs with a role in cancer;Esquela-Kerscher;Nat. Rev. Cancer,2006
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the versatility of miRNA-128: a comprehensive review on its role as a biomarker and therapeutic target in clinical pathways;Molecular Biology Reports;2024-07-28
2. MiR-128-3p inhibits the proliferation, migration and invasion of human nasopharyngeal carcinoma cells via EMT;Tropical Journal of Pharmaceutical Research;2024-02-05
3. miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer;International Journal of Molecular Sciences;2023-10-28
4. MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer;Cancer Biology & Therapy;2023-06-26
5. Integrative roles of sphingosine kinase in liver pathophysiology;Toxicological Research;2023-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3